Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Iradimed Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of IRMD: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders87180−6
Shares5.64M65.54M−101.3K (−1.8%)
Value$169.1M$0$156.7M−$12.4M (−7.3%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Iradimed Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to IRMD in Q4 2022
InstitutionSharesValue% of portfolio
LSV Asset Management18,300$518.0K0.00%
Citadel Advisors LLC15,145$428.5K0.00%
Man Group plc8,012$226.7K0.00%
Retirement Financial Solutions, LLC51$1.44K0.00%
Farther Finance Advisors, LLC24$6790.00%
GWM Advisors LLC132$40.00%
Massmutual Trust Co FSB9$00.00%

Sold out (13)

Institutions that held Iradimed Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (1)

Institutions that held Iradimed Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRMD in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Wipfli Financial Advisors LLC,6$0